Medical Ikkou, Last Fiscal Year Net Income Revised Downward by 7%, Dividend Revised Upward by 15 yen

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Mar 28, 2025 4:00 pm JST Revision

3353 Medical Ikkou Group Co.,Ltd 【J-GAAP】

Guidance Update Report

Medical Ikkou Group Co.,Ltd <3353> [TSE Std] announced a revision to its performance and dividend after the market closed on March 28th (16:00). The consolidated net income for the fiscal year ending February 2025 has decreased 6.6%, from the previous forecast of 1.21 billion yen to 1.13 billion yen (compared to 1.03 billion yen in the previous period), leading to a reduction in the profit growth rate from 16.5% to 8.8%.

Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the September to February period (2H) consolidated net income has decreased 16.0%, from the previous forecast of 0.5 billion yen to 0.42 billion yen (compared to 0.59 billion yen in the same period of the previous year), leading to an increase in the profit decline rate from 15.8% to 29.2%.

At the same time, the company has significantly increased its planned annual dividend for the last fiscal year from the original plan of 50 yen to 65 yen (compared to 45 yen in the previous period).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep - Feb, 2024 Prev	23,595	972	947	501	133.2	25	Oct 7, 2024	J-GAAP
Sep - Feb, 2024 New	25,635	822	947	421	112.0	40	Mar 28, 2025	J-GAAP
Revision Rate	+8.6%	-15.4%	0.0%	-16.0%	-15.9%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2025 Prev	46,260	1,800	1,800	1,210	321.7	50	Apr 5, 2024	J-GAAP
Feb, 2025 New	48,300	1,650	1,800	1,130	300.5	65	Mar 28, 2025	J-GAAP
Revision Rate	+4.4%	-8.3%	0.0%	-6.6%	-6.6%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep - Feb, 2023	22,450	956	1,055	595	158.5	25	Apr 5, 2024	J-GAAP
Sep - Feb, 2024 Guidance	25,635	822	947	421	112.0	40	Mar 28, 2025	J-GAAP
YoY	+14.2%	-14.0%	-10.2%	-29.2%	-29.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2023	33,897	935	1,227	759	202.2	40	Apr 7, 2023	J-GAAP
Feb, 2024	39,900	1,559	1,751	1,039	276.7	45	Apr 5, 2024	J-GAAP
Feb, 2025 Guidance	48,300	1,650	1,800	1,130	300.5	65	Mar 28, 2025	J-GAAP
YoY	+21.1%	+5.8%	+2.8%	+8.8%	+8.6%